echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Nat Med: Peripheral immune characteristics of PD-1 block response in patients with classic Hodgkin's lymphoma

    Nat Med: Peripheral immune characteristics of PD-1 block response in patients with classic Hodgkin's lymphoma

    • Last Update: 2021-04-16
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    PD-1 blockade is very effective for classic Hodgkin’s lymphomas (cHLs), which is manifested by frequent increase in the copy number of CD274 (PD-L1) and PDC1LG2 (PD-L2) on chromosome 9p24.


    Lymphoma immunity

    The study included 56 patients who participated in the CheckMate 205 phase II clinical trial (NCT02181738) and obtained peripheral immune characteristics that are responsive to PD-1 blockade.


    Fig.


    diagnosis

    In summary, these findings emphasize the role of the recently expanded, clonally diverse CD4+ T cells and innate effectors in the efficacy of PD-1 blockade in the treatment of cHL.


     

    Original source:

     

    Fathima Zumla Cader, et al.


    ncbi.
    nlm.
    nih.
    gov/32778827/" target="_blank" rel="noopener">A peripheral immune signature of responsiveness to PD -1 blockade in patients with classical Hodgkin lymphoma

    in this message
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.